
Syneos Health SYNH
Quarterly report 2023-Q2
added 05-16-2026
Syneos Health EBITDA per Share 2011-2026 | SYNH
Annual EBITDA per Share Syneos Health
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.32 | 6.02 | 4.95 | 4.63 | 4.2 | 2.02 | 3.97 | 3.6 | 2.22 | 1.73 | 0.79 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.32 | 0.79 | 3.68 |
Quarterly EBITDA per Share Syneos Health
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.57 | 0.21 | - | 2.95 | 2.34 | 1.31 | - | 2.75 | 1.92 | 1.14 | - | 2.55 | 1.41 | 1.01 | 0.8 | 2.43 | 1.74 | 0.85 | 0.77 | 2.36 | 1.62 | 0.75 | 0.14 | 0.09 | 0.48 | 0.93 | 0.81 | 1 | 1 | 0.87 | 0.74 | 1.03 | 0.86 | 0.76 | 0.3 | 0.71 | 0.37 | 0.56 | 0.11 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.95 | 0.09 | 1.15 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | ||
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 203.29 | -0.59 % | $ 22.6 B | ||
|
Celcuity
CELC
|
-3.68 | $ 89.05 | -3.83 % | $ 4.16 B | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-36.9 | $ 4.99 | 10.89 % | $ 6.64 M | ||
|
Castle Biosciences
CSTL
|
-0.07 | $ 21.13 | 0.24 % | $ 612 M | ||
|
Fulgent Genetics
FLGT
|
-2.18 | $ 18.9 | 2.16 % | $ 582 M | ||
|
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-1.46 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
10.5 | $ 145.57 | -4.12 % | $ 11.4 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-3.17 | $ 130.25 | 0.1 % | $ 16.3 B | ||
|
Illumina
ILMN
|
6.95 | $ 162.88 | 1.78 % | $ 25.2 B | ||
|
CareDx, Inc
CDNA
|
-0.3 | $ 23.33 | 2.55 % | $ 1.24 B | ||
|
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.38 | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
1.02 | $ 1.76 | 1.32 % | $ 7.79 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-1.51 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
5.64 | $ 100.82 | 0.84 % | $ 6.8 B | ||
|
Charles River Laboratories International
CRL
|
8.64 | $ 186.79 | -1.69 % | $ 9.26 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
Pacific Biosciences of California
PACB
|
-1.8 | $ 1.4 | 2.19 % | $ 420 M | ||
|
Medpace Holdings
MEDP
|
19.5 | $ 466.95 | 0.03 % | $ 13.5 B | ||
|
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
2.48 | $ 1 137.25 | -2.21 % | $ 23.4 B | ||
|
NeoGenomics
NEO
|
-0.62 | $ 11.29 | -1.35 % | $ 1.45 B | ||
|
Myriad Genetics
MYGN
|
-3.6 | $ 4.47 | -1.43 % | $ 414 M | ||
|
National Research Corporation
NRC
|
1.35 | $ 21.03 | 6.48 % | $ 471 M | ||
|
Natera
NTRA
|
-1.96 | $ 218.17 | -2.09 % | $ 29.8 B | ||
|
Personalis
PSNL
|
-0.87 | $ 9.8 | 0.51 % | $ 875 M | ||
|
Koninklijke Philips N.V.
PHG
|
2.69 | $ 25.71 | -2.98 % | $ 24.4 B | ||
|
Senseonics Holdings
SENS
|
-1.6 | $ 7.32 | -1.48 % | $ 305 M | ||
|
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
0.22 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
-2.2 | $ 2.03 | -1.02 % | $ 4.66 M | ||
|
Twist Bioscience Corporation
TWST
|
-1.86 | $ 68.35 | -2.44 % | $ 4.09 B | ||
|
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 267.67 | -1.3 % | $ 22.3 B | ||
|
Thermo Fisher Scientific
TMO
|
23.3 | $ 483.35 | -2.22 % | $ 182 B | ||
|
Trinity Biotech plc
TRIB
|
-0.06 | $ 0.68 | 2.94 % | $ 244 M | ||
|
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-4.34 | $ 9.22 | -0.81 % | $ 2 B | ||
|
Invitae Corporation
NVTA
|
0.2 | - | - | $ 21.2 M |